相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Baveno VII - Renewing consensus in portal hypertension
Roberto de Franchis et al.
JOURNAL OF HEPATOLOGY (2022)
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death
Mathias Jachs et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease
Georg Semmler et al.
HEPATOLOGY (2021)
Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease
Monica Pons et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
Prevention of First Decompensation in Advanced Chronic Liver Disease
Mattias Mandorfer et al.
CLINICS IN LIVER DISEASE (2021)
Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy
Mattias Mandorfer et al.
HEPATOLOGY (2020)
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices
Horia Stefanescu et al.
LIVER INTERNATIONAL (2020)
Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review
Mattias Mandorfer et al.
SEMINARS IN LIVER DISEASE (2020)
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
Candid Villanueva et al.
LANCET (2019)
Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity
M. Mandorfer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Non-invasive evaluation of portal hypertension using ultrasound elastography
Annalisa Berzigotti
JOURNAL OF HEPATOLOGY (2017)
Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)
Thomas Reiberger et al.
WIENER KLINISCHE WOCHENSCHRIFT (2017)
Development of hyperdynamic circulation and response to -blockers in compensated cirrhosis with portal hypertension
Candid Villanueva et al.
HEPATOLOGY (2016)
The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test
Stephanie Hametner et al.
PLOS ONE (2016)
Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension
Roberto de Franchis
JOURNAL OF HEPATOLOGY (2015)
Evaluation of a new balloon occlusion catheter specifically designed for measurement of hepatic venous pressure gradient
Arnulf Ferlitsch et al.
LIVER INTERNATIONAL (2015)
New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension
Philipp Schwabl et al.
LIVER INTERNATIONAL (2015)
Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C
A. Maieron et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis
Monika Ferlitsch et al.
HEPATOLOGY (2012)
Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension
Vincenzo La Mura et al.
GUT (2011)
The clinical use of HVPG measurements in chronic liver disease
Jaime Bosch et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2009)
分享论文
